Understanding Myeloma

Advocacy Opportunities for a Myeloma Patient/Care Partners: The Benefits of Paying It Forward

How can myeloma patients make an impact for others in the cancer community? Watch this Myeloma Patient Café as devoted myeloma advocates give their advice.

Published:

Myeloma News From ASH 2018: Patient Advocate Perspective

As part of our coverage of the 2018 American Society of Hematology (ASH) annual meeting, myeloma survivor and patient advocate Cindy Chmielewski shares her perspective on the latest news in multiple myeloma.

Published:

Is There a Racial or Ethnic Disparity in Myeloma Data?

At a recent town meeting in Atlanta, renowned myeloma expert Dr. Ajay Nooka discusses clinical trial research on the biological implications of more frequently diagnosed patient populations. Watch now to learn more.

Published:

Should MRD-Negative Patients Stay on Maintenance Therapy?

Is it safe for MRD-negative patients stop treatment? From the 2018 American Society of Hematology (ASH) annual meeting, myeloma expert Dr. Gareth Morgan joins Patient Power to share data-based recommendations on the use of maintenance therapy for MRD-negative status myeloma patients. Watch now to find out more.

Published:

Where Is Research Today on BiTEs and CAR-T Cell Therapy?

How are researchers harnessing the power of a patient’s T cells to treat myeloma? Watch now to hear myeloma experts Dr. Gareth Morgan and Dr. Mohit Trikha discuss recent innovations made in immunotherapy through the use of molecular biology and genetic engineering.

Published:

Are New Drug Options Changing Treatment Standards and Strategies for Myeloma?

With the addition of more options for therapy, how is the treatment landscape evolving for multiple myeloma? Is the standard of care changing? Tune in to find out now from noted myeloma expert Dr. Elisabet Manasanch.

Published:

Myeloma Expert Shares Highlights From ASH 2018

Patient Power founder Andrew Schorr is joined by multiple myeloma specialist Dr. James Berenson to discuss exciting research developments announced at the 2018 American Society of Hematology (ASH) annual meeting in an ever-changing treatment paradigm. Tune in to hear the latest news.

Published:

Myeloma News From ASH 2018: Groundbreaking Data for the Future of Myeloma

On-location in San Diego, at the 60th annual American Society of Hematology (ASH) meeting, leading myeloma expert Dr. Faith Davies joins Patient Power to share recent breakthroughs in multiple myeloma treatment research presented at the conference. Watch now to find out more.

Published:

News From ASH 2018: A Multitude of Options in Myeloma

Dr. Robert Orlowski from The University of Texas MD Anderson Cancer Center weighs in on the flurry of myeloma news out of the ASH 2018 meeting.

Published:

Showing 9 of 260 programs
Advertisement
Join Our Community Register for Events Read Our Latest Blog
Advertisement

Page last updated on June 5, 2014